Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors.
about
Recent developments in imaging of pancreatic neuroendocrine tumorsPrognostication and response assessment in liver and pancreatic tumors: The new imagingDynamic Contrast-Enhanced CT in Patients with Pancreatic CancerManagement of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphologyImaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in developmentPerfusion-CT--Can We Predict Acute Pancreatitis Outcome within the First 24 Hours from the Onset of Symptoms?Abdominal perfusion computed tomography.Non-invasive imaging for studying anti-angiogenic therapy effects.Characterizing venous vasculatures of hepatocellular carcinoma using a multi-breath-hold two-dimensional susceptibility weighted imaging.Computed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer--a prospective study.PET/CT in Oncology: Current Status and Perspectives.Protocol modifications for CT perfusion (CTp) examinations of abdomen-pelvic tumors: impact on radiation dose and data processing time.Whole-organ CT perfusion of the pancreas: impact of iterative reconstruction on image quality, perfusion parameters and radiation dose in 256-slice CT-preliminary findings.Imaging of the pancreas: Recent advancesAntiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.HCC and angiogenesis: possible targets and future directionsCT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.Pancreatic Perfusion CT in Early Stage of Severe Acute Pancreatitis.Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?Computed Tomography (CT) Perfusion in Abdominal Cancer: Technical Aspects.Differential diagnostic value of computed tomography perfusion combined with vascular endothelial growth factor expression in head and neck lesions.Reproducibility and variability of very low dose hepatic perfusion CT in metastatic liver disease.Micro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization.Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imPancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.A bioimage informatics based reconstruction of breast tumor microvasculature with computational blood flow predictions.CT perfusion in oncology: how to do it.Imaging techniques in pancreatic tumors.New acquisition techniques: fields of application.Angiogenesis in neuroendocrine tumors: therapeutic applications.Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors.New insights into the management of renal cell cancer.Neoangiogenesis in prostate cancerComputed tomography perfusion imaging as a potential imaging biomarker of colorectal cancer.Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.Correlation of iodine uptake and perfusion parameters between dual-energy CT imaging and first-pass dual-input perfusion CT in lung cancer.Isoattenuating insulinomas at biphasic contrast-enhanced CT: frequency, clinicopathologic features and perfusion characteristics.Contrast enhanced ultrasound with quantitative perfusion analysis for objective characterization of pancreatic ductal adenocarcinoma: A feasibility study.Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.Dynamic cone beam CT angiography of carotid and cerebral arteries using canine model.
P2860
Q27005697-48260342-84F9-4F84-9AB5-50213C6A2318Q27021568-4BD5457B-4163-4BD0-B76F-5CF81007D128Q28069587-CD8A923E-96B9-489C-A13D-D738AA9E1F46Q28078501-81398538-0218-4B07-862A-C95DE2561EF9Q28083433-F66CF0D7-40F9-4097-AE48-0F166C906895Q28552606-399B0DDD-08CB-451A-8883-2988212CE38EQ30420501-76822211-7871-4690-AE8B-4E8D2116DF5DQ30447988-B72572E9-EF2E-4EF0-ADAE-A4B499191431Q31120579-D472FE86-FF59-4557-BC49-84199D907178Q33638337-2DEB753D-3D6E-4D5D-8B3B-3ADC61B03BEAQ33665109-BE828600-1629-4A8C-86C1-73E11848E702Q33796799-440C8A9D-6100-45D5-ADEB-7CA42C88AEABQ35058508-064F6B3F-8D4F-46C2-B1BD-8D4F9DD1EABBQ35153035-C72CB6E7-FF5A-4E93-9B1D-B023EEF18E51Q35655488-D0646E9A-ED5B-4F12-A446-10E2149680ADQ35698574-DFC162F6-876F-4968-AF83-B74968C6CAA9Q35776891-9A21CB19-B88E-461A-A3DC-F1E357D615C0Q35821157-639D92A1-DF51-4DD5-B09F-EB812D98D43AQ36300517-29134D9E-5614-4B44-B9BA-B4E7308B7E1BQ36335156-A251D6F1-47EB-4162-BB53-7C6DBB65290CQ36825460-F5DAF203-AE30-474A-99FB-387BB37D779EQ37398599-0238C674-62AD-4201-A149-CFAC8445AC01Q37575598-77BA65B8-D2AE-4869-8627-048A3191B531Q37613344-BAEB6A45-5D46-470B-B402-7D3A8D8172CBQ37669053-022C47EC-C034-42A7-88D7-2851BA7837C5Q37688862-F1605F91-90B6-4021-8CB1-5404E33B0753Q37693472-5537574A-6130-4A8C-B6BC-D99009D7E3B1Q37705365-F8B7CD08-50BD-4698-AB6F-DFE3986CC999Q37876335-103EB71B-6B1B-4BE4-BEF4-68DAB03454FDQ38005887-E559C273-A754-42FA-B8F8-0C87B74450FDQ38038098-F4219DBB-E6BC-48BB-B6C1-06852769F89DQ38053049-2256F6E2-876F-45B4-87CC-74F562644493Q38193434-7AC2D68C-8A94-45E7-9A6A-D158B3846D3BQ38291492-E461D2D8-B5E3-40AD-88ED-4423E40B6D76Q38412364-A582E16E-A14C-4CC9-9494-2C91CE6C6A49Q38682442-B071BB07-552E-49C8-89BC-4E16D31930E4Q38713143-5A9098A9-4877-4545-ADCF-2EC39BF13A45Q38748854-41B1FB35-F071-4EF1-BEF3-F46B5B480A81Q38844841-5112C941-C642-4BCE-8867-34B06459B402Q40015081-59C31986-B052-4014-BA1E-E0CCB08D35D1
P2860
Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pancreatic endocrine tumors: t ...... lates with prognostic factors.
@en
Pancreatic endocrine tumors: t ...... lates with prognostic factors.
@nl
type
label
Pancreatic endocrine tumors: t ...... lates with prognostic factors.
@en
Pancreatic endocrine tumors: t ...... lates with prognostic factors.
@nl
prefLabel
Pancreatic endocrine tumors: t ...... lates with prognostic factors.
@en
Pancreatic endocrine tumors: t ...... lates with prognostic factors.
@nl
P2093
P50
P1433
P1476
Pancreatic endocrine tumors: t ...... lates with prognostic factors.
@en
P2093
Anne Couvelard
Gaspard d'Assignies
Marie-Pierre Vullierme
Olivia Hentic
Philippe Ruszniewski
Stéphane Bahrami
Valérie Vilgrain
P304
P356
10.1148/RADIOL.2501080291
P407
P577
2008-12-18T00:00:00Z